New Strong Sell Stocks for June 4th

In this article:

Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:

ASLAN Pharmaceuticals Limited ASLN operates as a clinical-stage biotechnology company. The Zacks Consensus Estimate for its current year earnings has been revised 14.3% downward over the last 30 days.

BioLineRx Ltd. BLRX is a biopharmaceutical development company. The Zacks Consensus Estimate for its current year earnings has been revised 17.7% downward over the last 30 days.

Flexion Therapeutics, Inc. FLXN is a specialty pharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 3.2% downward over the last 30 days.

Investcorp Credit Management BDC, Inc. ICMB is a business development company. The Zacks Consensus Estimate for its current year earnings has been revised 15.9% downward over the last 30 days.

Marinus Pharmaceuticals, Inc. MRNS is a clinical stage biopharmaceutical company. The Zacks Consensus Estimate for its current year earnings has been revised 38.5% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
BioLineRx Ltd. (BLRX) : Free Stock Analysis Report
 
Flexion Therapeutics, Inc. (FLXN) : Free Stock Analysis Report
 
Marinus Pharmaceuticals, Inc. (MRNS) : Free Stock Analysis Report
 
ASLAN Pharmaceuticals Ltd. (ASLN) : Free Stock Analysis Report
 
Investcorp Credit Management BDC, Inc. (ICMB) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research

Advertisement